Introduction: Non-invasive diagnosis of atherosclerosis via single biomarkers has been attempted but remains elusive. The aim of the current study is to use urine proteomics in ApoE -/-mice to discover proteins with pathophysiological roles in atherogenesis and to identify urinary polypeptide patterns reflecting early stages of atherosclerosis. Methods and Results: Urine of ApoE -/-mice either on high fat diet (HFD) or chow diet (CD) was collected over 15 weeks. Capillary electrophoresis coupled to mass spectrometry (CE-MS) of samples identified 16 polypeptides specific for ApoE -/-mice on HFD. In a blinded test set, these polypeptides allowed identification of atherosclerosis at a sensitivity of 95% and specificity of 90%. Sequencing of the discovered polypeptides identified fragments of α 1 -antitrypsin, EGF, kidney androgen regulated protein (KAP) and collagen. Using immunohistochemistry, α 1 -antitrypsin, EGF and collagen type I was shown to be highly expressed in atherosclerotic plaques of ApoE -/-mice on HFD. Urinary excretion levels of collagen and α 1 -antitrypsin fragments also significantly correlated with intraplaque collagen and α 1 -antitrypsin content, mirroring plaque protein expression in the urine proteome. To provide further confirmation that the newly identified proteins are relevant in humans, presence of collagen type I, α 1 -antitrypsin, and EGF was also confirmed in human atherosclerotic disease. Conclusions: Urine proteome analysis in mice exemplifies the potential of a novel multimarker approach for non-invasive detection of atherosclerosis and monitoring of disease progression. Furthermore, this approach represents a novel discovery tool for the identification of proteins relevant in murine and human atherosclerosis and thus also defines potential novel therapeutic targets.
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